Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.42 USD | +0.08% | +2.14% | -11.16% |
Feb. 23 | Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue | MT |
Feb. 22 | Transcript : Dynavax Technologies Corporation, Q4 2023 Earnings Call, Feb 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.16% | 1.62B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock Dynavax Technologies Corporation - Nasdaq
- News Dynavax Technologies Corporation
- Dynavax Technologies : Gets CHMP Positive Opinion for Heplisav-B Two Dose Adult Hepatitis B Adjuvanted Vaccine